Science/Environment Things more likely to give you blood clots than Covid vaccines.

Remove this Banner Ad

1. Covid-19


Professor Sir Munir Pirmohamed, the chair of the Committee of Human Medicines, has stressed how it is "important to remember COVID-19 itself causes clotting and it causes lower platelets".

He also said despite more women getting blood clots after the jab, there is no evidence women are more likely to develop them.

He outlined how a recent paper had found:

• Pulmonary embolism, or clotting on the lungs, occurs in 7.8% of people who have COVID-19
• Deep vein thrombosis (DVT), or clotting in the legs, occurs in 11.2% of people who have COVID-19
• Of those who have COVID-19 and end up in an intensive therapy unit (ITU), 23% will have some form of clot
• COVID-19 causes strokes in 1.6% of people
• Up to 30% of people who have COVID-19 will get thrombocytopenia, which is a lowering of the platelet count.

skynews-vaccine-astrazeneca_5333508.jpg
 
Aug 21, 2016
15,617
24,587
AFL Club
Geelong
Other Teams
Oldham
The March data is more applicable. For under 30s in the UK there currently appears to be more risk from the vaccine than Covid-19. Hence MHRA policy changing so that those aged 18-29 will be offered an alternative vaccine, where available.

1617942145181.png
 

Log in to remove this ad.

  • Thread starter
  • Admin
  • #4
The March data is more applicable. For under 30s in the UK there currently appears to be more risk from the vaccine than Covid-19. Hence MHRA policy changing so that those aged 18-29 will be offered an alternative vaccine, where available.

View attachment 1097871
ICU admission.

Nothing about long term neurological effects.
 
1. Covid-19


Professor Sir Munir Pirmohamed, the chair of the Committee of Human Medicines, has stressed how it is "important to remember COVID-19 itself causes clotting and it causes lower platelets".

He also said despite more women getting blood clots after the jab, there is no evidence women are more likely to develop them.

He outlined how a recent paper had found:

• Pulmonary embolism, or clotting on the lungs, occurs in 7.8% of people who have COVID-19
• Deep vein thrombosis (DVT), or clotting in the legs, occurs in 11.2% of people who have COVID-19
• Of those who have COVID-19 and end up in an intensive therapy unit (ITU), 23% will have some form of clot
• COVID-19 causes strokes in 1.6% of people
• Up to 30% of people who have COVID-19 will get thrombocytopenia, which is a lowering of the platelet count.

skynews-vaccine-astrazeneca_5333508.jpg


Trivialising a genuine safety issue in the way that you do isn't helpful.
 
Aug 21, 2016
15,617
24,587
AFL Club
Geelong
Other Teams
Oldham
ICU admission.

Nothing about long term neurological effects.

Correct. Long term neurological effects don't appear to be a consideration in the decision to move away from the AstraZeneca vaccine for younger people.

ATAGI (Australian Technical Advisory Group on Immunisation) consider that the individual benefit-to-risk balance of vaccination with COVID-19 vaccine AstraZeneca in Australia varies with age. The risk of ongoing health issues and death from COVID-19 is highest in older age groups, particularly rising from 50 years of age. By comparison, the rate, and thus possibility of disability and death from TTS (Thrombosis with thrombocytopenia syndrome) may be higher in younger people. This age-specific benefit-to-risk balance is demonstrated in an analysis from the UK.

The UK is currently at "low exposure risk". By the time the vaccine is rolled out to the under 40s, between May and July, the exposure risk will be lower again.
The UK's joint committee on vaccination and immunisation (JCVI) have said a fresh risk/benefit assessment of the vaccine in different age brackets would be made before the rollout reaches those under the age of 40. Australia would be currently be at "minimal exposure risk".
 
Aug 21, 2016
15,617
24,587
AFL Club
Geelong
Other Teams
Oldham
Apparently the least expensive the vaccine the more likely it is to give you blood clots and be "paused".

AstraZeneca $2.15
Johnson and Johnson $10
Pfizer $19.50
Moderna $30
 

swingdog

Norm Smith Medallist
Aug 3, 2007
9,434
12,375
Melbourne
AFL Club
West Coast
Apparently the least expensive the vaccine the more likely it is to give you blood clots and be "paused".

AstraZeneca $2.15
Johnson and Johnson $10
Pfizer $19.50
Moderna $30

Has any clotting been reported from either the Russian or Chinese vaccines? I'm assuming that even if there had been clotting, it may be 'under-reported'.
 

(Log in to remove this ad.)

armpit

Norm Smith Medallist
Aug 8, 2013
5,055
3,902
AFL Club
Fremantle
Has any clotting been reported from either the Russian or Chinese vaccines? I'm assuming that even if there had been clotting, it may be 'under-reported'.
These days everything seems to be either over reported or under reported.
 
The Chinese vaccine seems to bring on an overwhelming desire to sleep hanging upside down.

jokes aside, the feedback on the chinese vaccine is pretty meh. apparently costs around USD 30 a dose, and is rumoured to be around 50% effective

zero word on the russian program (russians are sayings its over 90% effective, but no independent study has been done to validate this)
 
Theres also 1 in 100000 chance of getting anaphylaxis from the pfizer vaccine, but you barely hear about this at all

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine | Vaccination | JAMA | JAMA Network

In the general population, anaphylaxis is 1 in 5000 anyway. Anybody who has allergies, might want to talk to their specialist first and be alert to the onset.

A friend only a couple of days ago posted pics of his anaphylaxis in hospital, he looked terrible and I assumed he must have had the jab but he hasn't had it yet.
 
Aug 21, 2016
15,617
24,587
AFL Club
Geelong
Other Teams
Oldham
True, I haven't seen data for second dose. I am aware that reactions tend to be more severe after the second pfizer (muscle aches, temperature typically)

I'm not sure if it's what Chief was alluding to but I think if you were going to get an anaphylactic reaction it would be from the first dose and if you did then you would avoid the second dose.
 
Aug 21, 2016
15,617
24,587
AFL Club
Geelong
Other Teams
Oldham
There's a few separate issues worth discussion.

The risk of immediate adverse effects of the vaccines can be balanced against the risk from Covid-19 for a given age group and other cohorts. For example, the Australian authorities have determined that the risk from Covid-19 for under 50s is lower than the risk from the AstraZeneca vaccine.

Should we vaccinate children given that they have minimal risk of getting sick from this virus?

Should we vaccinate people who have had Covid-19 then recovered and so are immune?

The longer term effects of the new vaccines are unknown.
 

Remove this Banner Ad

Back